Carrie Jones, Ph.D.
Associate Professor, Pharmacology & Neuroscience
Director of In Vivo and Translational Pharmacology & Development Director, Warren Center for Neuroscience Drug Discovery (WCNDD)
- : carrie.jones@Vanderbilt.Edu
- : (615) 322-6347
- :
418B Preston Research Building
- : More Information/Publications
Areas of Interest: Neuroscience; High-Throughput Technology; Mass Spectrometry & Omics Analysis; Nanotechnology; Imaging; Antibody & Protein Expression
Member: VCNDD
As a highly trained in vivo neuropharmacologist and neuroscientist with expertise in the use of biochemical, neurochemical, behavioral and imaging methodologies, I am interested in understanding how modulation of different muscarinic acetylcholine receptor (mAChR) and/or metabotropic glutamate receptor (mGluR) subtypes in limbic and cortical brain regions influence normal affective and cognitive functions and contribute to the underlying pathophysiology of various central nervous system (CNS) disorders, such as schizophrenia, Alzheimer’s disease (AD), depression and addiction.